Free-cash-flow proxy decreased 506.7%
Free-cash-flow proxy changed -506.7% from the comparable as-filed period.
-$331.4M→-$2.0B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →APLD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 179.8%
Operating income changed -179.8% from the comparable as-filed period.
-$22.3M→-$62.4M2 prior comparisons
Operating margin moved 1098 bp higher
Operating margin changed +1098 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-34.72%→-23.74%2 prior comparisons
Revenue increased 309.2%
Revenue changed +309.2% from the comparable as-filed period.
$64.2M→$262.8M2 prior comparisons
Gross margin moved 692 bp lower
Gross margin changed -692 basis points from the comparable as-filed period.
13.41%→6.49%2 prior comparisons
Trade receivables increased 291.7%
Trade receivables changed +291.7% from the comparable as-filed period.
$29.1M→$114.1M3 prior comparisons
Total assets increased 388.0%
Total assets changed +388.0% from the comparable as-filed period.
$2.4B→$11.7B3 prior comparisons
Stockholders' equity increased 53.5%
Stockholders' equity changed +53.5% from the comparable as-filed period.
$1.0B→$1.6B2 prior comparisons
Stock-based compensation increased 330.0%
Stock-based compensation changed +330.0% from the comparable as-filed period.
$15.5M→$66.5M2 prior comparisons
Selling, general & administrative increased 293.4%
Selling, general & administrative changed +293.4% from the comparable as-filed period.
$29.2M→$114.7M2 prior comparisons
Cost of revenue increased 341.9%
Cost of revenue changed +341.9% from the comparable as-filed period.
$55.6M→$245.7M2 prior comparisons
Capital expenditure increased 731.8%
Capital expenditure changed +731.8% from the comparable as-filed period.
$249.4M→$2.1B2 prior comparisons
Current liabilities increased 61.7%
Current liabilities changed +61.7% from the comparable as-filed period.
$985.5M→$1.6B3 prior comparisons
Current assets increased 536.2%
Current assets changed +536.2% from the comparable as-filed period.
$641.7M→$4.1B3 prior comparisons
Capex / revenue moved 40119 bp higher
Capex / revenue changed +40119 basis points from the comparable as-filed period.
388.41%→789.59%2 prior comparisons
Free-cash-flow proxy decreased 186.3%
Free-cash-flow proxy changed -186.3% from the comparable as-filed period.
-$251.6M→-$720.2M0 prior comparisons
Operating income decreased 352.2%
Operating income changed -352.2% from the comparable as-filed period.
-$18.9M→-$85.7M0 prior comparisons
Operating cash flow increased 832.8%
Operating cash flow changed +832.8% from the comparable as-filed period.
$5.9M→$55.0M0 prior comparisons
Operating margin moved 3185 bp lower
Operating margin changed -3185 basis points from the comparable as-filed period.
-35.79%→-67.65%0 prior comparisons
Net income decreased 98.4%
Net income changed -98.4% from the comparable as-filed period.
-$35.6M→-$70.6M0 prior comparisons
Gross margin moved 3534 bp higher
Gross margin changed +3534 basis points from the comparable as-filed period.
7.14%→42.49%0 prior comparisons
Revenue increased 139.3%
Revenue changed +139.3% from the comparable as-filed period.
$52.9M→$126.6M0 prior comparisons
Current assets increased 785.4%
Current assets changed +785.4% from the comparable as-filed period.
$274.3M→$2.4B2 prior comparisons
Current liabilities increased 159.0%
Current liabilities changed +159.0% from the comparable as-filed period.
$393.6M→$1.0B2 prior comparisons
Total assets increased 265.9%
Total assets changed +265.9% from the comparable as-filed period.
$1.7B→$6.2B2 prior comparisons
Shares outstanding increased 27.2%
Shares outstanding changed +27.2% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
224,717,713→285,769,5396 prior comparisons
Selling, general & administrative increased 250.8%
Selling, general & administrative changed +250.8% from the comparable as-filed period.
$22.7M→$79.7M0 prior comparisons
Capex / revenue moved 12559 bp higher
Capex / revenue changed +12559 basis points from the comparable as-filed period.
486.56%→612.15%0 prior comparisons
Capital expenditure increased 201.1%
Capital expenditure changed +201.1% from the comparable as-filed period.
$257.5M→$775.2M0 prior comparisons
Cost of revenue increased 48.2%
Cost of revenue changed +48.2% from the comparable as-filed period.
$49.1M→$72.8M0 prior comparisons
Stock-based compensation increased 417.5%
Stock-based compensation changed +417.5% from the comparable as-filed period.
$9.7M→$50.1M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.